Literature DB >> 10788967

Pulmonary toxicity of inhaled aerosolized prostacyclin therapy--an observational study.

P V van Heerden1, P Caterina, P Filion, D V Spagnolo, N M Gibbs.   

Abstract

Large white/landrace piglets (mass 11 to 21 kg) were exposed to aerosolized alkaline glycine diluent (n = 2) or inhaled aerosolized prostacyclin (n = 2) for five to eight hours. Pigs receiving these aerosols developed mild acute sterile tracheitis, involving the superficial layers of the trachea, shown histologically and ultrastructurally. Pigs receiving the diluent aerosol also showed mild inflammatory changes in the bronchioles. These findings suggest caution with the use of high volumes of aerosolized alkaline glycine diluent during inhaled aerosolized prostacyclin therapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10788967     DOI: 10.1177/0310057X0002800206

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN: 0310-057X            Impact factor:   1.669


  7 in total

Review 1.  Inhaled pulmonary vasodilators: a narrative review.

Authors:  Kai Liu; Huan Wang; Shen-Ji Yu; Guo-Wei Tu; Zhe Luo
Journal:  Ann Transl Med       Date:  2021-04

2.  Inhaled Pulmonary Vasodilators in Cardiac Surgery Patients: Correct Answer Is "NO".

Authors:  Fumito Ichinose; Warren M Zapol
Journal:  Anesth Analg       Date:  2017-08       Impact factor: 5.108

3.  Toxicity of prolonged high dose inhaled PGE1 in ventilated neonatal pigs.

Authors:  Beena G Sood; Elizabeth J Dawe; Krishna Rao Maddipati; Monica Malian; Xinguang Chen; Robert Galli; Raja Rabah
Journal:  Pulm Pharmacol Ther       Date:  2008-02-06       Impact factor: 3.410

4.  Inhaled PLGA particles of prostaglandin E₁ ameliorate symptoms and progression of pulmonary hypertension at a reduced dosing frequency.

Authors:  Vivek Gupta; Nilesh Gupta; Imam H Shaik; Reza Mehvar; Eva Nozik-Grayck; Ivan F McMurtry; Masahiko Oka; Masanobu Komatsu; Fakhrul Ahsan
Journal:  Mol Pharm       Date:  2013-03-26       Impact factor: 4.939

5.  Aerosolized PGE1: a selective pulmonary vasodilator in neonatal hypoxemic respiratory failure results of a Phase I/II open label clinical trial.

Authors:  Beena G Sood; Virginia Delaney-Black; Jacob V Aranda; Seetha Shankaran
Journal:  Pediatr Res       Date:  2004-08-04       Impact factor: 3.756

Review 6.  Fundamentals of aerosol therapy in critical care.

Authors:  Jayesh Dhanani; John F Fraser; Hak-Kim Chan; Jordi Rello; Jeremy Cohen; Jason A Roberts
Journal:  Crit Care       Date:  2016-10-07       Impact factor: 9.097

7.  Inhaled PGE1 in neonates with hypoxemic respiratory failure: two pilot feasibility randomized clinical trials.

Authors:  Beena G Sood; Martin Keszler; Meena Garg; Jonathan M Klein; Robin Ohls; Namasivayam Ambalavanan; C Michael Cotten; Monica Malian; Pablo J Sanchez; Satyan Lakshminrusimha; Leif D Nelin; Krisa P Van Meurs; Rebecca Bara; Shampa Saha; Abhik Das; Dennis Wallace; Rosemary D Higgins; Seetha Shankaran
Journal:  Trials       Date:  2014-12-12       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.